BSc, MSc, PhD (Molecular Parasitology)
Scientist D
ICMR- Regional Medical Research Centre, NE, Dibrugarh
I am Dr. Md Atique Ahmed, Scientist D at ICMR-RMRCNE, Dibrugarh. My research is dedicated to advancing medical innovation through the development of low-cost, ultra-sensitive diagnostic assays and devices. Leveraging cutting-edge technologies such as CRISPR-Cas, Recombinase Polymerase Amplification (RPA), and novel protein identification and expression studies, our division is at the forefront of revolutionizing diagnostic practices.
Biotechnology, Molecular Diagnostics, Point of Care Diagnostics, CRISPR-Cas Technologies, Infectious diseases and malaria
Our lab specializes in utilizing advanced technologies to enhance diagnostic processes. We aim to transform disease detection and diagnosis by providing rapid, accurate, and cost-effective solutions. Our work is centered on improving early disease detection, enhancing patient outcomes, and contributing to global health efforts.
Our lab specializes in utilizing advanced technologies to enhance diagnostic processes. We are particularly focused on the development of point-of-care assays that provide rapid, accurate, and cost-effective solutions for disease detection. Our division is a leader in medical innovation, particularly in developing low-cost devices and applying CRISPR-Cas technology for diagnostic assay development. By leveraging the precision and versatility of the CRISPR-Cas system, we aim to revolutionize the detection and diagnosis of various diseases. Our goal is to improve early disease detection, enhance patient outcomes, and contribute to global health efforts through innovative diagnostic tools. Our work not only advances scientific knowledge but also has the potential to make a significant impact on public health by enabling more personalized and precise medical care.
ICMR-RMRCNE, Dibrugarh, and Meril Diagnostics Pvt Ltd have signed an MoA for the technology transfer of a CRISPR-Cas-based TB detection system developed by Dr Md Atique Ahmed & his team which has a turnaround time of ~3 hrs, this will add up to the efforts for TB elimination.
My background in molecular genetics has been enriched by extensive international experience. During my PhD and Postdoctoral research, I have worked on malaria-related molecular genetics projects across Malaysia, South Korea, and the United Kingdom. This global exposure has provided me with a comprehensive perspective on the challenges and innovations in the field. My expertise in molecular genetics and genomics informs my commitment to developing innovative diagnostic technologies.
List of Projects implemented:
1. Title: Development of rapid point of care diagnostics and drug resistance monitoring techniques for malaria in Northeast India using highly sensitive CRISPR based molecular tools.
2. Title: Microbial Detection within minutes: Development of rapid, low-cost, ultra-sensitive, mobile app based CRISPR Technologies for detection of clinically important bacterial infections and drug resistance.
3. Title: Field deployable CRISPR technologies for rapid, ultra-sensitive detection of malaria transmission biomarkers and sub-microscopic asymptomatic cases.
4. Title: Optimization and external validation of a CRISPR-Cas based tuberculosis detection system.
Group Working under Dr. Md Atique Ahmed
_logo.svg.png){kind=logo}
